Devex Examines Meningitis Vaccine Project, Lessons For Similar Efforts

Devex: Combating meningitis in sub-Saharan Africa and what the future holds
“…[P]ublic health officials across [Africa], along with the World Health Organization and PATH, formed the Meningitis Vaccine Project. This partnership — along with the Serum Institute of India — designed, developed, and produced MenAfriVac, the first vaccine for use specifically in Africa, with African leaders at the table. … So why was the meningitis A campaign so successful? And how can its success encourage other vaccination efforts on the continent?…” (Cousins, 3/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.